Scientific Reports,
Journal Year:
2023,
Volume and Issue:
13(1)
Published: Nov. 17, 2023
Dengue
virus
(DENV)
infection
remains
a
challenging
health
threat
worldwide.
Ubiquitin-specific
protease
18
(USP18),
which
preserves
the
anti-interferon
(IFN)
effect,
is
an
ideal
target
through
DENV
mediates
its
own
immune
evasion.
However,
much
of
function
and
mechanism
USP18
in
regulating
replication
incompletely
understood.
In
addition,
whether
regulates
merely
by
causing
IFN
hyporesponsiveness
not
clear.
present
study,
using
several
different
approaches
to
block
signaling,
including
neutralizing
antibodies
(Abs),
anti-IFN
receptor
Abs,
Janus
kinase
inhibitors
alpha
beta
subunit
1
(IFNAR1)knockout
cells,
we
showed
that
may
regulate
IFN-associated
IFN-unassociated
manners.
Localized
mitochondria,
regulated
release
mitochondrial
DNA
(mtDNA)
cytosol
affect
viral
replication,
mechanisms
such
as
reactive
oxygen
species
(mtROS)
production,
changes
membrane
potential,
mobilization
calcium
into
8-oxoguanine
glycosylase
(OGG1)
expression,
oxidation
fragmentation
mtDNA,
opening
permeability
transition
pore
(mPTP)
were
involved
USP18-regulated
mtDNA
cytosol.
We
therefore
identify
machineries
are
association
with
effects.
Cell Reports Medicine,
Journal Year:
2024,
Volume and Issue:
5(5), P. 101522 - 101522
Published: May 1, 2024
Neuroinflammation
plays
a
significant
role
in
ischemic
injury,
which
can
be
promoted
by
oxidized
mitochondrial
DNA
(Ox-mtDNA).
Cytidine/uridine
monophosphate
kinase
2
(CMPK2)
regulates
mtDNA
replication,
but
its
neuroinflammation
and
injury
remains
unknown.
Here,
we
report
that
CMPK2
expression
is
upregulated
monocytes/macrophages
microglia
post-stroke
humans
mice,
respectively.
Microglia/macrophage
knockdown
using
the
Cre
recombination-dependent
adeno-associated
virus
suppresses
inflammatory
responses
brain,
reduces
infarcts,
improves
neurological
outcomes
CX3CR1Cre/ERT2
mice.
Mechanistically,
limits
newly
synthesized
Ox-mtDNA
formation
subsequently
blocks
NLRP3
inflammasome
activation
microglia/macrophages.
Nordihydroguaiaretic
acid
(NDGA),
as
inhibitor,
discovered
to
reduce
mice
prevent
primary
human
monocytes
from
patients.
Thus,
these
findings
identify
promising
therapeutic
target
for
stroke
other
brain
disorders
associated
with
neuroinflammation.
Neurotherapeutics,
Journal Year:
2024,
Volume and Issue:
21(4), P. e00368 - e00368
Published: April 30, 2024
In
the
context
of
stroke
and
revascularization
therapy,
brain
ischemia-reperfusion
injury
is
a
significant
challenge
that
leads
to
oxidative
stress
inflammation.
Central
cell's
intrinsic
immunity
cGAS-STING
pathway,
which
typically
activated
by
unusual
DNA
structures.
The
involvement
oxidized
mitochondrial
(ox-mtDNA)-an
byproduct-in
this
type
neurological
damage
has
not
been
fully
explored.
This
study
among
first
examine
effect
ox-mtDNA
on
innate
neurons
following
injury.
Using
rat
model
transient
middle
cerebral
artery
occlusion
cellular
oxygen-glucose
deprivation/reoxygenation,
we
have
discovered
activates
pathway
in
neurons.
Importantly,
pharmacologically
limiting
release
into
cytoplasm
reduces
inflammation
improves
functions.
Our
findings
suggest
targeting
may
be
valuable
strategy
attenuate
therapy
for
acute
ischemic
stroke.
Translational Neurodegeneration,
Journal Year:
2024,
Volume and Issue:
13(1)
Published: April 17, 2024
Abstract
Mitochondria
have
multiple
functions
such
as
supplying
energy,
regulating
the
redox
status,
and
producing
proteins
encoded
by
an
independent
genome.
They
are
closely
related
to
physiology
pathology
of
many
organs
tissues,
among
which
brain
is
particularly
prominent.
The
demands
20%
resting
metabolic
rate
holds
highly
active
mitochondrial
activities.
Considerable
research
shows
that
mitochondria
function,
while
defects
induce
or
exacerbate
in
brain.
In
this
review,
we
provide
comprehensive
advances
biology
involved
functions,
well
mitochondria-dependent
cellular
events
pathology.
Furthermore,
various
perspectives
explored
better
identify
roles
neurological
diseases
neurophenotypes
diseases.
Finally,
therapies
discussed.
Mitochondrial-targeting
therapeutics
showing
great
potentials
treatment
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Aug. 27, 2024
The
escape
of
mitochondrial
double-stranded
dsRNA
(mt-dsRNA)
into
the
cytosol
has
been
recently
linked
to
a
number
inflammatory
diseases.
Here,
we
report
that
release
mt-dsRNA
is
general
feature
senescent
cells
and
critical
driver
their
secretome,
known
as
senescence-associated
secretory
phenotype
(SASP).
Inhibition
RNA
polymerase,
sensors
RIGI
MDA5,
or
master
signaling
protein
MAVS,
all
result
in
reduced
expression
SASP,
while
broadly
preserving
other
hallmarks
senescence.
Moreover,
are
hypersensitized
mt-dsRNA-driven
inflammation
due
levels
PNPT1
ADAR1,
two
proteins
for
mitigating
accumulation
potency
dsRNA,
respectively.
We
find
mitofusin
MFN1,
but
not
MFN2,
important
activation
mt-dsRNA/MAVS/SASP
axis
and,
accordingly,
genetic
pharmacologic
MFN1
inhibition
attenuates
SASP.
Finally,
within
fibrotic
aged
tissues
present
foci,
polymerase
reduces
systemic
associated
In
conclusion,
uncover
mt-dsRNA/MAVS/MFN1
key
SASP
identify
novel
therapeutic
strategies
authors
show
Critical Care,
Journal Year:
2024,
Volume and Issue:
28(1)
Published: Sept. 3, 2024
Sepsis
is
a
severe
medical
condition
characterized
by
systemic
inflammatory
response,
often
culminating
in
multiple
organ
dysfunction
and
high
mortality
rates.
In
recent
years,
there
has
been
growing
recognition
of
the
pivotal
role
played
mitochondrial
damage
driving
progression
sepsis.
Various
factors
contribute
to
impairment
during
sepsis,
encompassing
mechanisms
such
as
reactive
nitrogen/oxygen
species
generation,
mitophagy
inhibition,
dynamics
change,
membrane
permeabilization.
Damaged
mitochondria
actively
participate
shaping
milieu
triggering
key
signaling
pathways,
including
those
mediated
Toll-like
receptors,
NOD-like
cyclic
GMP-AMP
synthase.
Consequently,
surge
interest
developing
therapeutic
strategies
targeting
mitigate
septic
pathogenesis.
This
review
aims
delve
into
intricate
underpinning
sepsis
its
significant
impact
on
immune
dysregulation.
Moreover,
we
spotlight
promising
mitochondria-targeted
interventions
that
have
demonstrated
efficacy
preclinical
models.
ACS Applied Materials & Interfaces,
Journal Year:
2024,
Volume and Issue:
16(11), P. 13509 - 13524
Published: March 11, 2024
Elesclomol
(ES),
a
copper-binding
ionophore,
forms
an
ES–Cu
complex
with
copper
ions
(Cu(II)).
has
been
proven
to
induce
mitochondrial
oxidative
stress
and
copper-dependent
cell
death
(cuprotosis).
However,
is
poorly
water-soluble,
its
delivery
various
cancer
cells
challenge.
Herein,
we
designed
d-α-tocopherol
polyethylene
glycol
1000
succinate/chondroitin
sulfate-cholic
acid
(TPGS/CS–CA)-based
micellar
nanoparticle
for
delivering
the
lines
demonstrate
efficacy
as
anticancer
agent.
The
nanoparticles
exerted
high
encapsulation
efficiency
excellent
serum
stability.
of
was
evaluated
in
drug-sensitive
(DU145,
PC3,
A549)
drug-resistant
(DU145TXR,
PC3TXR,
A549TXR).
results
showed
that
potent
activities
both
lines.
Western
blotting,
reverse
transcription
quantitative
polymerase
chain
reaction
(RT-qPCR),
molecular
docking
suggested
not
substrate
P
glycoprotein
(P-gp),
which
efflux
transporter
potentially
causing
multidrug
resistance
(MDR)
cells.
could
bypass
P-gp
without
compromising
their
activity,
indicating
they
may
overcome
MDR
provide
novel
therapeutic
strategy.
Additionally,
extracellular
matrix
nanoparticles-pretreated
polarize
Raw
264.7
macrophages
into
M1
phenotype.
Therefore,
our
TPGS/CS–CA-based
effective
method
complex,
promising
strategy
therapy
potential
immune
response
stimulation.
Human Molecular Genetics,
Journal Year:
2024,
Volume and Issue:
33(R1), P. R80 - R91
Published: May 22, 2024
Abstract
Mitochondria
are
pleiotropic
organelles
central
to
an
array
of
cellular
pathways
including
metabolism,
signal
transduction,
and
programmed
cell
death.
also
key
drivers
mammalian
immune
responses,
functioning
as
scaffolds
for
innate
signaling,
governing
metabolic
switches
required
activation,
releasing
agonists
that
promote
inflammation.
Mitochondrial
DNA
(mtDNA)
is
a
potent
immunostimulatory
agonist,
triggering
pro-inflammatory
type
I
interferon
responses
in
host
types.
Here
we
review
recent
advances
how
mtDNA
detected
by
nucleic
acid
sensors
the
system
upon
release
into
cytoplasm
extracellular
space.
We
discuss
interplay
between
sensing
impacts
endpoints
relevant
health
disease.